A Six-Month Randomized Controlled Trial of Whole Soy and Isoflavones Daidzein on Body Composition in Equol-Producing Postmenopausal Women with Prehypertension
Objectives. This paper reported the effects of commonly used whole soy foods (soy flour) and purified daidzein (one of the major isoflavones and the precursor of equol) on changes in anthropometric measurements and body composition in a 6-month double-blind, randomized, placebo-controlled trial amon...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Journal of Obesity |
| Online Access: | http://dx.doi.org/10.1155/2013/359763 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832566878462017536 |
|---|---|
| author | Zhao-min Liu Suzanne C. Ho Yu-ming Chen Jean Woo |
| author_facet | Zhao-min Liu Suzanne C. Ho Yu-ming Chen Jean Woo |
| author_sort | Zhao-min Liu |
| collection | DOAJ |
| description | Objectives. This paper reported the effects of commonly used whole soy foods (soy flour) and purified daidzein (one of the major isoflavones and the precursor of equol) on changes in anthropometric measurements and body composition in a 6-month double-blind, randomized, placebo-controlled trial among prehypertensive postmenopausal women who are also equol producers. Methods. 270 eligible women were randomized to either one of the three treatments: 40 g soy flour (whole soy group), 40 g low-fat milk powder + 63 mg daidzein (daidzein group), or 40 g low-fat milk powder (placebo group) daily each for 6 months. Anthropometric indicators and body composition were measured before and after intervention. Results. 253 subjects completed the study with good compliance. Urinary isoflavones levels suggested good compliance of subjects with supplementation. Whole soy and purified daidzein had no significant effect on body weight, body mass index (BMI), waist and hip circumferences, waist to hip ratio (WHR), body fat percentage, fat mass, and free fat mass. Conclusion. Six-month consumption of whole soy and purified daidzein at provided dosage had no improvement on body weight and composition compared with isocaloric milk placebo among prehypertensive equol-producing postmenopausal women. This trial is registered with ClinicalTrials.gov NCT01270737. |
| format | Article |
| id | doaj-art-121afc1774534a0eba8e68454b41528d |
| institution | Kabale University |
| issn | 2090-0708 2090-0716 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Obesity |
| spelling | doaj-art-121afc1774534a0eba8e68454b41528d2025-02-03T01:02:54ZengWileyJournal of Obesity2090-07082090-07162013-01-01201310.1155/2013/359763359763A Six-Month Randomized Controlled Trial of Whole Soy and Isoflavones Daidzein on Body Composition in Equol-Producing Postmenopausal Women with PrehypertensionZhao-min Liu0Suzanne C. Ho1Yu-ming Chen2Jean Woo3Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong KongDivision of Epidemiology, The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong KongDepartment of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou 510080, ChinaDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong KongObjectives. This paper reported the effects of commonly used whole soy foods (soy flour) and purified daidzein (one of the major isoflavones and the precursor of equol) on changes in anthropometric measurements and body composition in a 6-month double-blind, randomized, placebo-controlled trial among prehypertensive postmenopausal women who are also equol producers. Methods. 270 eligible women were randomized to either one of the three treatments: 40 g soy flour (whole soy group), 40 g low-fat milk powder + 63 mg daidzein (daidzein group), or 40 g low-fat milk powder (placebo group) daily each for 6 months. Anthropometric indicators and body composition were measured before and after intervention. Results. 253 subjects completed the study with good compliance. Urinary isoflavones levels suggested good compliance of subjects with supplementation. Whole soy and purified daidzein had no significant effect on body weight, body mass index (BMI), waist and hip circumferences, waist to hip ratio (WHR), body fat percentage, fat mass, and free fat mass. Conclusion. Six-month consumption of whole soy and purified daidzein at provided dosage had no improvement on body weight and composition compared with isocaloric milk placebo among prehypertensive equol-producing postmenopausal women. This trial is registered with ClinicalTrials.gov NCT01270737.http://dx.doi.org/10.1155/2013/359763 |
| spellingShingle | Zhao-min Liu Suzanne C. Ho Yu-ming Chen Jean Woo A Six-Month Randomized Controlled Trial of Whole Soy and Isoflavones Daidzein on Body Composition in Equol-Producing Postmenopausal Women with Prehypertension Journal of Obesity |
| title | A Six-Month Randomized Controlled Trial of Whole Soy and Isoflavones Daidzein on Body Composition in Equol-Producing Postmenopausal Women with Prehypertension |
| title_full | A Six-Month Randomized Controlled Trial of Whole Soy and Isoflavones Daidzein on Body Composition in Equol-Producing Postmenopausal Women with Prehypertension |
| title_fullStr | A Six-Month Randomized Controlled Trial of Whole Soy and Isoflavones Daidzein on Body Composition in Equol-Producing Postmenopausal Women with Prehypertension |
| title_full_unstemmed | A Six-Month Randomized Controlled Trial of Whole Soy and Isoflavones Daidzein on Body Composition in Equol-Producing Postmenopausal Women with Prehypertension |
| title_short | A Six-Month Randomized Controlled Trial of Whole Soy and Isoflavones Daidzein on Body Composition in Equol-Producing Postmenopausal Women with Prehypertension |
| title_sort | six month randomized controlled trial of whole soy and isoflavones daidzein on body composition in equol producing postmenopausal women with prehypertension |
| url | http://dx.doi.org/10.1155/2013/359763 |
| work_keys_str_mv | AT zhaominliu asixmonthrandomizedcontrolledtrialofwholesoyandisoflavonesdaidzeinonbodycompositioninequolproducingpostmenopausalwomenwithprehypertension AT suzannecho asixmonthrandomizedcontrolledtrialofwholesoyandisoflavonesdaidzeinonbodycompositioninequolproducingpostmenopausalwomenwithprehypertension AT yumingchen asixmonthrandomizedcontrolledtrialofwholesoyandisoflavonesdaidzeinonbodycompositioninequolproducingpostmenopausalwomenwithprehypertension AT jeanwoo asixmonthrandomizedcontrolledtrialofwholesoyandisoflavonesdaidzeinonbodycompositioninequolproducingpostmenopausalwomenwithprehypertension AT zhaominliu sixmonthrandomizedcontrolledtrialofwholesoyandisoflavonesdaidzeinonbodycompositioninequolproducingpostmenopausalwomenwithprehypertension AT suzannecho sixmonthrandomizedcontrolledtrialofwholesoyandisoflavonesdaidzeinonbodycompositioninequolproducingpostmenopausalwomenwithprehypertension AT yumingchen sixmonthrandomizedcontrolledtrialofwholesoyandisoflavonesdaidzeinonbodycompositioninequolproducingpostmenopausalwomenwithprehypertension AT jeanwoo sixmonthrandomizedcontrolledtrialofwholesoyandisoflavonesdaidzeinonbodycompositioninequolproducingpostmenopausalwomenwithprehypertension |